Clinical Trials Browser

INDUSTRY × perifosine × Clear all

Colonic Neoplasms

NCT00398710 2018-03-15

A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

Phase 2 Completed

37 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT00847366 2018-03-15

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Phase NA Completed

10 enrolled

BreastSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma

NCT00391560 2018-03-14

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

Phase 2 Completed

19 enrolled

Other hematologic neoplasm

Leukemia

NCT00398879 2018-03-14

Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients

Phase 2 Completed

381 enrolled

Gastrointestinal

Colonic Neoplasms

NCT01224730 2018-03-14

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

Phase 1 Completed

24 enrolled

Tumor-Agnostic

Neoplasms

NCT00389077 2018-03-07

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

Phase 2 Completed

558 enrolled

Lymphoid

Lymphoma, Neoplasms

NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

Phase 2 Completed

72 enrolled

Sarcoma

Chondrosarcoma, Sarcoma, Alveolar Soft Part

NCT00448721 2018-03-01

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Phase 2 Completed

24 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00375791 2018-02-28

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

Phase 2 Completed

67 enrolled

Plasma cell

Multiple Myeloma

NCT00401011 2018-02-23

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

Phase 1/2 Completed

84 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT00399789 2018-02-22

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

Phase 1/2 Completed

121 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00455559 2018-02-22

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Phase 2 Completed

40 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01002248 2018-02-09

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Phase 3 Terminated

135 enrolled

Plasma cell

Multiple Myeloma

NCT00498966 2018-02-05

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Phase 2 Completed

50 enrolled

Genitourinary

Kidney Neoplasms

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Phase 1 Completed

30 enrolled

GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT00399152 2014-02-19

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Phase 1 Completed

15 enrolled

Genitourinary

Kidney Neoplasms

NCT00398697 2014-02-13

Phase I Perifosine and Gemcitabine Study

Phase 1 Completed

19 enrolled

Tumor-Agnostic

Neoplasms

NCT00399087 2014-02-13

Phase I Trial of Docetaxel With Perifosine

Phase 1 Completed

39 enrolled

Tumor-Agnostic

Neoplasms

NCT00399126 2014-02-13

Phase I Trial of Paclitaxel With Perifosine

Phase 1 Completed

24 enrolled

Tumor-Agnostic

Neoplasms

NCT01097018 2013-07-02

X-PECT

Phase 3 Completed

468 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00415064 2012-07-06

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

Phase 1 Completed

32 enrolled

Plasma cell

Multiple Myeloma

Clinical Trials

Study of Perifosine + Capecitabine for Colon Cancer Patients

A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Phase I Perifosine and Gemcitabine Study

Phase I Trial of Docetaxel With Perifosine

Phase I Trial of Paclitaxel With Perifosine

X-PECT

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma